The United States will pay the pharmaceutical company Pfizer $ 1.95 billion to produce and deliver 100 million doses of the company’s COVID-19 vaccine candidate in case the drug is effective in human trials, the company said in a press release on Wednesday. Pfizer will administer the vaccine when the …
Read More »
Text size The future of US stocks fell on Wednesday morning, as Wall Street was concerned about continuing tensions between the US and China, as well as continuing fears about the coronavirus and the cost it has affected. to the economy. On the US-China front, tensions escalated after the US …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »
AstraZeneca Plc fell from a record in New York trade after data for the company’s Covid-19 vaccine candidate, while promising, fueled concerns about whether it can match competitors. Bernstein analysts led by Ronny Gal said the vaccine, developed in association with the University of Oxford, showed initial positive data, but …
Read More »
The UK government said on Monday it has secured early access to 90 million doses of vaccines from two potential COVID-19 vaccines developed by a partnership between Germany’s BioNTech and US drug maker Pfizer, as well as one by the group. French Valneva. The business ministry said it had signed …
Read More »